October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.
October 29, 2008 - Critical Diagnostics today announced the publication of a research paper and an accompanying editorial comment further refining the clinical value and risk of mortality prediction power of the cardiac biomarker soluble ST2 (sST2).
Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported low viscosity allows it to reach distal vessels. It also has the lowest osmolality of all nonionic monomers in the U.S. Together, these properties facilitate ease of injection, help improve patient comfort and provide visualization and image quality.
Covidien's Optistar Elite contrast delivery system injects contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.
OASIS 1.2T MRI is designed to deliver high performance and patient comfort. The Oasis open architecture, High-Field strength, Zenith RF technology and fast gradients drive diagnostic confidence and image quality.
October 29, 2008 - To offer hospitals more versatility and a seamless transition from endovascular imaging to surgical intervention on a single system, Toshiba America Medical Systems Inc. is partnering with surgical table manufacturer MAQUET to provide new solutions for Toshiba’s Infinix-i product line.
October 28, 2008 - The Los Angeles Brain and Spine Institute yesterday said George Rappard, M.D., a neurointerventional surgeon in Glendale, CA is the first physician west of the Rockies to treat a patient using an FDA-approved liquid system for treating wide-necked brain aneurysms.
October 28, 2008 - The diagnosis and subsequent treatment of cardiovascular disease can be accomplished through a variety of medical imaging modalities, and demonstrating the effectiveness of a multimodality approach is Salinas Valley Memorial Healthcare System.
October 28, 2008 – Thermedical said yesterday it received a $3.6 million competing phase two renewal grant from the National Heart, Lung and Blood Institute, which will fund continued development and testing of the company’s Saline Enhanced Radiofrequency Ablation (SERF) system, which is designed for use in ablation treatment for ventricular tachycardia (VT).
The Stellant D CT Injection System is a full-featured, dual syringe injection system that reportedly enables clinicians to perform the most critical CT contrast exams, including cardiac CT and Coronary CTA, with advances like DualFlow simultaneous saline and contrast delivery, P3T Cardiac personalized patient protocol, XDS Extravasation Detector and the Medrad Informatics System to integrate injec
